Test ID TPNT Troponin T, Serum
Useful For
Exclusion diagnosis of acute myocardial infarction
Monitoring acute coronary syndromes and estimating prognosis
Possible utility in monitoring patients with nonischemic causes of cardiac injury
Troponin T is the cardiac marker of choice for the Mayo Health System for the evaluation of patients with possible cardiovascular injury
Method Name
Electrochemiluminescent Immunoassay
Reporting Name
Troponin T, SSpecimen Type
SerumCollection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Serum gel tubes should be centrifuged within 2 hours of collection.
2. Red-top tubes should be centrifuged and aliquoted within 2 hours of collection.
Forms: If not ordering electronically, complete, print, and send a Cardiovascular Test Request Form (T724) with the specimen (http://www.mayomedicallaboratories.com/it-mmfiles/cardiovascular-request-form.pdf).
Specimen Minimum Volume
0.3 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
Serum | Frozen (preferred) | 365 days |
Refrigerated | 24 hours |
Clinical Information
Troponin T is a myofibrillar protein found in striated musculature. There are 2 types of myofilament, a thick filament containing myosin and a thin filament consisting of 3 different proteins: actin, tropomyosin, and troponin. Troponin is itself a complex of 3 protein subunits: troponin T, troponin I, and troponin C. Troponin T binds the troponin complex to tropomyosin. Troponin I inhibits actomyosin ATPase in relation to the calcium concentration. Troponin C, with its 4 binding sites for calcium, mediates calcium dependency.
In the cytosol, troponin T is found in both free and protein-bound forms. The unbound (free) pool of troponin T is the source of the troponin T released in the early stages of myocardial damage. Bound troponin T is released from the structural elements at a later stage, corresponding with the degradation of myofibrils that occurs in irreversible myocardial damage. The most common cause of cardiac injury is myocardial ischemia, ie, acute myocardial infarction. Troponin T becomes elevated 2 to 4 hours after the onset of myocardial necrosis, and can remain elevated for up to 14 days.
Elevations in troponin T are also seen in patients with unstable angina. The finding of unstable angina and an elevated troponin T are known to have adverse short- and long-term prognoses, as well as a unique beneficial response to an invasive interventional strategy and treatment with the newer antiplatelet agents and low-molecular-weight heparin.
Reference Values
<0.01 ng/mL
Values ≥0.01 ng/mL have been shown to have prognostic value.
Cautions
As with all markers of cardiac injury, elevations of troponin T do not in and of themselves indicate the presence of an ischemic mechanism. Many other disease states are associated with elevations of troponin T via mechanisms different from those that cause injury in patients with acute coronary syndromes. These include trauma (eg, contusion, ablation, or pacing), congestive heart failure, hypertension, hypotension (often with arrhythmias), pulmonary embolism, renal failure, and myocarditis.
Day(s) Performed
Monday through Sunday; Continuously
Report Available
Same day/1 dayPerforming Laboratory

Test Classification
This test has been cleared or approved by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
84484